Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2A
|
pubmed:dateCreated |
1994-7-25
|
pubmed:abstractText |
The antitumor activity of a sequential combination of 5-fluorouracil (5-FU) and carboplatin (JM-8) was evaluated using gastric cancer cell lines in vitro and in vivo. In the in vitro study, the sequence of 5-FU followed by JM-8 showed higher antitumor activity than that of the reverse sequence. The sequence of 5-FU at 5 micrograms/ml for 24 h followed by 5 micrograms/ml JM-8 for 24 h showed antitumor activity almost equivalent to that of 10 micrograms/ml 5-FU for 24 h and higher activity than that of 10 micrograms/ml JM-8 for 24 h on two cell lines. To evaluate the antitumor activity and toxicity of 5-FU and JM-8 in vivo, BALB/cA nu/nu mice bearing human gastric cancer xenografts St-15, St-40 and SC-1-NU were administered 5-FU and JM-8 intraperitoneally. The sequence of 5-FU prior to JM-8 showed higher antitumor activity than that of the reverse sequence on all the xenografts, and simultaneous administration of 5-FU and JM-8 showed the most potent antitumor activity on St-40 and SC-1-NU. On the other hand, the sequence of 5-FU before JM-8 showed the lowest toxicity in all the treated groups, in terms of death rate, body weight loss and spleen weight loss. This combination is thought to be a promising chemotherapy regimen, showing high antitumor activity without an increment of toxicity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
461-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8017848-Adenocarcinoma,
pubmed-meshheading:8017848-Animals,
pubmed-meshheading:8017848-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8017848-Carboplatin,
pubmed-meshheading:8017848-Cell Line,
pubmed-meshheading:8017848-Cell Survival,
pubmed-meshheading:8017848-Dose-Response Relationship, Drug,
pubmed-meshheading:8017848-Fluorouracil,
pubmed-meshheading:8017848-Humans,
pubmed-meshheading:8017848-Mice,
pubmed-meshheading:8017848-Mice, Nude,
pubmed-meshheading:8017848-Stomach Neoplasms,
pubmed-meshheading:8017848-Transplantation, Heterologous,
pubmed-meshheading:8017848-Tumor Cells, Cultured
|
pubmed:articleTitle |
Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
|
pubmed:affiliation |
Department of Surgery, School of Medicine, Keio University, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|